Medical and Pharmaceutical Wave Life Sciences shares pop 50% on positive clinical data for common type of muscular dystrophy Duchenne muscular dystrophy is a severe, progressive genetic disorder that primarily affects boys Joseph MortonSeptember 24, 2024
Medical and Pharmaceutical UK researchers conduct successful trials with saliva ‘dip’ lung cancer test Their findings have been published in the Royal Society of Chemistry's Analyst journal Rowan DunneSeptember 20, 2024
Medical and Pharmaceutical Fertility solutions provider Progyny tanks after losing top client Progyny's termination by the unnamed client in January will result in a 13% loss of revenue, approximately Rowan DunneSeptember 19, 2024
Medical and Pharmaceutical Edgewise Therapetics shares skyrocket on positive clinical trial returns The company stock rose 55 per cent after results of one dose show immediate results Joseph MortonSeptember 19, 2024
Medical and Pharmaceutical From Kentucky to Nevada: $6.8M grant aims to spread lung cancer screening success Kentucky has more cases of lung cancer than any other state, but it has one of the highest screening rates Rowan DunneSeptember 19, 2024
Medical and Pharmaceutical UK hospital starts using advanced robotic tool for early-stage lung cancer detection This "Ion Endoluminal System" enables doctors to access hard-to-reach areas of the lungs Rowan DunneSeptember 18, 2024
Medical and Pharmaceutical New drug could open personalized treatment strategies for prostate cancer Screening men for BCL2 could allow for the development of personalized treatment plans Joseph MortonSeptember 17, 2024
Medical and Pharmaceutical New Brunswick to use blood testing method for identifying lung cancer This will be the first time that labs in Atlantic Canada utilize liquid biopsies to test for the disease Rowan DunneSeptember 16, 2024
Medical and Pharmaceutical Prelude Therapeutics Incorporated shares drop 30% on clinical trial news The drug in question is also presently being tested in an ongoing dose-escalation Phase 1 trial for patients with solid tumours Joseph MortonSeptember 13, 2024
Medical and Pharmaceutical H.C. Wainwright raises share target for Instil Bio by US$15 Instil Bio stock rose by nearly 57% on Thursday due to this prediction and other recent developments Rowan DunneSeptember 12, 2024